Production Of GlaxoSmithKline Plc's Ziagen HIV Oral Liquid...

Palabras clave

Bottles of Ziagen, an HIV oral liquid medication, move down the... Fotografía de noticiasAsistencia sanitaria y medicina,Botella,Canadá,Doctor,EE.UU.,Embalaje,Finanzas,Horizontal,Las Américas,Líquido,Medicina,Mississauga,Ontario - Canadá,SIDA,Sede central,Toronto,Usar la boca,VIHPhotographer Collection: Bloomberg 2010 BloombergBottles of Ziagen, an HIV oral liquid medication, move down the packaging line at the GlaxoSmithKline Canada Inc. headquarters in Mississauga, Ontario, Canada, on Monday, Dec. 13, 2010. Global sales of existing HIV medicines will peak at $12 billion in 2012, then halve by 2019 as patent expiries increase competition from generic drugs, according to a report by Datamonitor Group earlier this year. Photographer: Norm Betts/Bloomberg via Getty Images